Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Oncolytic herpes simplex virus-1 (oHSV)–based vectors selectively replicate in tumor cells causing direct killing, ie., oncolysis, while sparing normal cells. oHSV’sare promising anticancer agents, but their efficacy, when used as single agents, leaves room for improvement. We hypothesized that comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Passer, Brent J., Cheema, Tooba, Wu, Shulin, Wu, Chen-lee, Rabkin, Samuel D., Martuza, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810211/
https://www.ncbi.nlm.nih.gov/pubmed/23138870
http://dx.doi.org/10.1038/cgt.2012.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810211/
https://www.ncbi.nlm.nih.gov/pubmed/23138870
http://dx.doi.org/10.1038/cgt.2012.75

Ejemplares similares